NM

Nitinkumar Makvana

Active Director Director DIN 09254155
DIN 09254155 First appointment Jul 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Nitinkumar Makvana

Data last updated:

Nitinkumar Makvana is a Director at Sycon Clinical Research Private Limited (since 2021). The company operates in Pharma. Sycon Clinical Research Private Limited reported revenue of ₹4.10 Cr (FY 2025).

DIN 09254155
Primary Designation Director
Industry Pharma
First Appointment 26 Jul 2021
Oldest Company Age 5 yrs
Largest company Sycon Clinical Research Private Limited · ₹4.10 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jul 20212021₹4.10 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Sycon Clinical Research Private Limited
Premium access

Shareholding and investment profile for Nitinkumar Makvana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitinkumar Makvana

Nitinkumar Makvana currently holds 1 directorship: Sycon Clinical Research Private Limited (Director, since 26 Jul 2021, revenue ₹4.10 Cr (FY 2025)).

Nitinkumar Makvana was first appointed on 26 Jul 2021 as Director at Sycon Clinical Research Private Limited.

The current boards of Nitinkumar Makvana's companies include Bhavikkumar Ramanlal Patel (Sycon Clinical Research Private Limited), Kamlesh Manilal Panchal (Sycon Clinical Research Private Limited), Umang Chandulal Gandhi (Sycon Clinical Research Private Limited), Viralkumar Kirtikumar Patel (Sycon Clinical Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available